Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1422540-88-2
1859379-85-3 | Propargyl-PEG2-acid | AA019E2O | MFCD29764323
134179-43-4 | Ms-PEG4-azide | AA019E5X | MFCD20134119
2098983-14-1 | T-Boc-aminooxy-peg2-ch2co2h | AA019EAR | MFCD30730369
1351373-46-0 | Bis-propargyl-PEG8 | AA019EF5 | MFCD31580135
150159-13-0 | 6,7-Dihydro-1-methyl-pyrrolo[2,3-c]azepine-4,8(1h,5h)-dione | AA019EIC | MFCD12964900
1446012-36-7 | tert-butyl (2R,5S)-2-(hydroxymethyl)-1-oxa-7-azaspiro[4.4]nonane-7-carboxylate | AA019ELN | MFCD31758475
1779764-91-8 | 6-(Methylamino)imidazo[1,2-b]pyridazine-3-carboxylic acid | AA019EON | MFCD29917036
885396-64-5 | 4-bromo-N-(5-fluoro-2-methylphenyl)benzenesulfonamide | AA019ERY | MFCD05139658
854015-42-2 | ethyl 5-bromo-4-methylisoxazole-3-carboxylate | AA019EUX | MFCD28661157
951442-84-5 | (Z)-2-Chloro-N'-hydroxybenzimidamide | AA019EXI | MFCD00859262
